These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 15253741)
41. Evaluation of oxidative stress after repeated intravenous iron supplementation. Mimić-Oka J; Savić-Radojević A; Pljesa-Ercegovac M; Opacić M; Simić T; Dimković N; Simić DV Ren Fail; 2005; 27(3):345-51. PubMed ID: 15957553 [TBL] [Abstract][Full Text] [Related]
42. Effects of intravenous iron on mononuclear cells during the haemodialysis session. Martin-Malo A; Merino A; Carracedo J; Alvarez-Lara MA; Ojeda R; Soriano S; Crespo R; Ramirez R; Aljama P Nephrol Dial Transplant; 2012 Jun; 27(6):2465-71. PubMed ID: 22207322 [TBL] [Abstract][Full Text] [Related]
43. Protein oxidative stress and dyslipidemia in dialysis patients. Marques de Mattos A; Marino LV; Ovidio PP; Jordão AA; Almeida CC; Chiarello PG Ther Apher Dial; 2012 Feb; 16(1):68-74. PubMed ID: 22248198 [TBL] [Abstract][Full Text] [Related]
44. The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels. Galli F; Benedetti S; Buoncristiani U; Piroddi M; Conte C; Canestrari F; Buoncristiani E; Floridi A Kidney Int; 2003 Aug; 64(2):748-55. PubMed ID: 12846775 [TBL] [Abstract][Full Text] [Related]
45. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis. Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416 [TBL] [Abstract][Full Text] [Related]
46. Intravenous iron-gluconate during haemodialysis modifies plasma beta2-microglobulin properties and levels. Michelis R; Sela S; Kristal B Nephrol Dial Transplant; 2005 Sep; 20(9):1963-9. PubMed ID: 15956071 [TBL] [Abstract][Full Text] [Related]
47. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Attallah N; Osman-Malik Y; Frinak S; Besarab A Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942 [TBL] [Abstract][Full Text] [Related]
48. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178 [TBL] [Abstract][Full Text] [Related]
49. Serum levels of protein carbonyl, a marker of oxidative stress, are associated with overhydration, sarcopenia and mortality in hemodialysis patients. Song YR; Kim JK; Lee HS; Kim SG; Choi EK BMC Nephrol; 2020 Jul; 21(1):281. PubMed ID: 32677905 [TBL] [Abstract][Full Text] [Related]
50. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Kalantar-Zadeh K; Don BR; Rodriguez RA; Humphreys MH Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181 [TBL] [Abstract][Full Text] [Related]
51. Plasma protein thiolation index (PTI) as a biomarker of thiol-specific oxidative stress in haemodialyzed patients. Colombo G; Reggiani F; Podestà MA; Garavaglia ML; Portinaro NM; Milzani A; Badalamenti S; Dalle-Donne I Free Radic Biol Med; 2015 Dec; 89():443-51. PubMed ID: 26453922 [TBL] [Abstract][Full Text] [Related]
52. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress. Yang CC; Hsu SP; Wu MS; Hsu SM; Chien CT Kidney Int; 2006 Feb; 69(4):706-14. PubMed ID: 16395251 [TBL] [Abstract][Full Text] [Related]
53. Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade. Agarwal R Am J Physiol Renal Physiol; 2003 Apr; 284(4):F863-9. PubMed ID: 12505865 [TBL] [Abstract][Full Text] [Related]
54. The effect of intravenous iron on oxidative stress in hemodialysis patients at various levels of vitamin C. Eiselt J; Racek J; Opatrný K; Trefil L; Stehlík P Blood Purif; 2006; 24(5-6):531-7. PubMed ID: 17077626 [TBL] [Abstract][Full Text] [Related]
55. Albumin thiol oxidation and serum protein carbonyl formation are progressively enhanced with advancing stages of chronic kidney disease. Matsuyama Y; Terawaki H; Terada T; Era S Clin Exp Nephrol; 2009 Aug; 13(4):308-315. PubMed ID: 19363646 [TBL] [Abstract][Full Text] [Related]
56. Protein thiol oxidation and lipid peroxidation in patients with uraemia. Prakash M; Upadhya S; Prabhu R Scand J Clin Lab Invest; 2004; 64(6):599-604. PubMed ID: 15370466 [TBL] [Abstract][Full Text] [Related]
57. Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients. Nguyen-Khoa T; Massy ZA; Witko-Sarsat V; Thévenin M; Touam M; Lambrey G; Lacour B; Drüeke TB; Descamps-Latscha B Kidney Int; 1999 Aug; 56(2):747-53. PubMed ID: 10432417 [TBL] [Abstract][Full Text] [Related]
58. Decrease in reduced-form albumin among chronic kidney disease patients: new insights in cardiovascular complications. Terawaki H; Era S; Nakayama M; Hosoya T Ther Apher Dial; 2011 Apr; 15(2):156-60. PubMed ID: 21426508 [TBL] [Abstract][Full Text] [Related]
59. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients. Prats M; Font R; García C; Muñoz-Cortés M; Cabré C; Jariod M; Romeu M; Giralt M; Martinez-Vea A Clin Nephrol; 2014 Jun; 81(6):419-26. PubMed ID: 24691014 [TBL] [Abstract][Full Text] [Related]
60. Electrolyzed-reduced water reduced hemodialysis-induced erythrocyte impairment in end-stage renal disease patients. Huang KC; Yang CC; Hsu SP; Lee KT; Liu HW; Morisawa S; Otsubo K; Chien CT Kidney Int; 2006 Jul; 70(2):391-8. PubMed ID: 16760903 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]